[Asymmetric hypertrophy of the myocardium in patients with hypertension (echocardiographic data)]

Kardiologiia
|February 1, 1983
PubMed

Insights

Asymmetrical hypertrophy of the ventricular septum, a condition seen in hypertensive disease, can be diagnosed using echocardiography. This condition affects myocardial function and can lead to left ventricular outflow tract obstruction, detectable with a nitroglycerin test.

Area of Science:

  • Cardiology
  • Medical Imaging
  • Hypertension Research

Context:

  • Hypertensive disease is a common condition with various cardiovascular complications.
  • Asymmetrical hypertrophy of the ventricular septum (AHVS) is a specific manifestation within hypertensive heart disease.
  • Echocardiography is a key diagnostic tool in cardiovascular medicine.

Purpose:

  • To detail the diagnostic utility of echocardiography for identifying asymmetrical hypertrophy of the ventricular septum in hypertensive patients.
  • To investigate the impact of AHVS on myocardial function and left ventricular (LV) outflow tract.
  • To evaluate the effectiveness of the nitroglycerin test in revealing functional obstruction in AHVS.

Summary:

  • Asymmetrical hypertrophy of the ventricular septum was observed in 4-5% of hypertensive patients.
  • Echocardiographic findings indicate preserved contractile function but affected dilatation in these patients.
  • A nitroglycerin test can reveal functional signs of LV outflow tract obstruction in individuals with AHVS.

Impact:

  • This study enhances the understanding of AHVS diagnosis and its functional consequences in hypertensive disease.
  • It highlights echocardiography's role in detecting subtle cardiac changes.
  • The findings may inform clinical management strategies for hypertensive patients with septal hypertrophy and outflow obstruction.

Related Concept Videos

Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...